<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhao CC</submitter><funding>the Translational Medicine National Key Science and Technology Infrastructure Open Project</funding><funding>the National Key Research and Development Plan</funding><funding>National Natural Science Foundation of China</funding><funding>Shanghai Research Center for Endocrine and Metabolic Diseases</funding><funding>the Exploratory Clinical Research Project of Shanghai Jiao Tong University Affiliated Sixth People's Hospital</funding><pagination>105</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10197852</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Bilirubin has been found to protect against overt atherosclerotic diseases, but to date, few studies have investigated the effects of bilirubin especially within the normal range on lower limb atherosclerosis. Therefore, we aimed to assess the associations of bilirubin within normal limits including total bilirubin (TB), conjugated bilirubin (CB) and unconjugated bilirubin (UCB) with lower limb atherosclerosis in Chinese patients with type 2 diabetes mellitus (T2DM).&lt;h4>Methods&lt;/h4>7284 T2DM patients with normal levels of serum bilirubin were included in this cross-sectional, real-world study. Patients were divided into quintiles by TB levels (&lt; 8.7, 8.7-10.19, 10.20-11.99, 12-13.99, > 13.99 µmol/L). Lower limb ultrasonography was conducted to detect lower limb plaque an</pubmed_abstract><journal>Diabetology &amp; metabolic syndrome</journal><pubmed_title>High-normal serum bilirubin decreased the risk of lower limb atherosclerosis in type 2 diabetes: a real-world study.</pubmed_title><pmcid>PMC10197852</pmcid><funding_grant_id>82100876</funding_grant_id><funding_grant_id>2018YFC1314905</funding_grant_id><funding_grant_id>81170759</funding_grant_id><funding_grant_id>81502316</funding_grant_id><funding_grant_id>ynts202105</funding_grant_id><funding_grant_id>2022ZZ01002</funding_grant_id><funding_grant_id>TMSK-2021-116</funding_grant_id><pubmed_authors>Li LX</pubmed_authors><pubmed_authors>Li MF</pubmed_authors><pubmed_authors>Chen MY</pubmed_authors><pubmed_authors>Zhao CC</pubmed_authors><pubmed_authors>Wang JW</pubmed_authors><pubmed_authors>Ke JF</pubmed_authors></additional><is_claimable>false</is_claimable><name>High-normal serum bilirubin decreased the risk of lower limb atherosclerosis in type 2 diabetes: a real-world study.</name><description>&lt;h4>Background&lt;/h4>Bilirubin has been found to protect against overt atherosclerotic diseases, but to date, few studies have investigated the effects of bilirubin especially within the normal range on lower limb atherosclerosis. Therefore, we aimed to assess the associations of bilirubin within normal limits including total bilirubin (TB), conjugated bilirubin (CB) and unconjugated bilirubin (UCB) with lower limb atherosclerosis in Chinese patients with type 2 diabetes mellitus (T2DM).&lt;h4>Methods&lt;/h4>7284 T2DM patients with normal levels of serum bilirubin were included in this cross-sectional, real-world study. Patients were divided into quintiles by TB levels (&lt; 8.7, 8.7-10.19, 10.20-11.99, 12-13.99, > 13.99 µmol/L). Lower limb ultrasonography was conducted to detect lower limb plaque an</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-26T17:27:15.096Z</modification><creation>2025-04-06T15:29:09.127Z</creation></dates><accession>S-EPMC10197852</accession><cross_references><pubmed>37208703</pubmed><doi>10.1186/s13098-023-01088-9</doi></cross_references></HashMap>